IRIS
COMELLI, Marina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.741
AS - Asia 3.531
EU - Europa 2.929
SA - Sud America 511
AF - Africa 68
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 4
Totale 14.792
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.599
SG - Singapore 1.628
UA - Ucraina 848
CN - Cina 827
IT - Italia 426
BR - Brasile 410
DE - Germania 386
HK - Hong Kong 377
FI - Finlandia 319
FR - Francia 287
VN - Vietnam 193
RU - Federazione Russa 192
IE - Irlanda 141
SE - Svezia 125
IN - India 116
CA - Canada 93
KR - Corea 92
GB - Regno Unito 85
TR - Turchia 63
BD - Bangladesh 40
AR - Argentina 36
IR - Iran 32
MX - Messico 28
IQ - Iraq 22
ZA - Sudafrica 19
PK - Pakistan 17
PL - Polonia 17
BE - Belgio 16
EC - Ecuador 16
JP - Giappone 16
VE - Venezuela 16
ES - Italia 14
ID - Indonesia 14
NL - Olanda 14
CO - Colombia 12
UZ - Uzbekistan 12
AT - Austria 10
JO - Giordania 9
SA - Arabia Saudita 9
EU - Europa 8
MA - Marocco 8
EG - Egitto 7
IL - Israele 7
LT - Lituania 7
MY - Malesia 7
BO - Bolivia 6
CZ - Repubblica Ceca 6
DZ - Algeria 6
KE - Kenya 6
PE - Perù 6
PH - Filippine 6
AE - Emirati Arabi Uniti 5
AZ - Azerbaigian 5
CL - Cile 5
KZ - Kazakistan 5
NP - Nepal 5
TG - Togo 5
TN - Tunisia 5
AL - Albania 4
AU - Australia 4
BY - Bielorussia 4
KG - Kirghizistan 4
LK - Sri Lanka 4
CH - Svizzera 3
CR - Costa Rica 3
HN - Honduras 3
IS - Islanda 3
JM - Giamaica 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
BB - Barbados 2
BG - Bulgaria 2
BH - Bahrain 2
ET - Etiopia 2
GR - Grecia 2
LA - Repubblica Popolare Democratica del Laos 2
MD - Moldavia 2
NG - Nigeria 2
NI - Nicaragua 2
NO - Norvegia 2
PA - Panama 2
TH - Thailandia 2
TW - Taiwan 2
AG - Antigua e Barbuda 1
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BZ - Belize 1
CI - Costa d'Avorio 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GF - Guiana Francese 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
HU - Ungheria 1
KH - Cambogia 1
KW - Kuwait 1
LR - Liberia 1
ME - Montenegro 1
Totale 14.775
Salva come PNG Salva come JPEG
Città #
Ann Arbor 832
Singapore 752
Woodbridge 606
Jacksonville 602
Houston 580
Ashburn 513
Fairfield 502
Chandler 444
Beijing 410
Hong Kong 377
Dearborn 336
San Jose 288
Wilmington 212
Seattle 163
Boardman 156
Udine 143
Council Bluffs 137
Dublin 137
Princeton 135
Lauterbourg 130
Cambridge 126
Los Angeles 106
Hefei 92
Seoul 90
The Dalles 76
Buffalo 75
Dallas 63
Helsinki 56
Ho Chi Minh City 55
Munich 51
Ottawa 50
New York 49
Hanoi 42
Izmir 40
São Paulo 37
Orem 36
Redondo Beach 32
San Diego 30
Ogden 29
Mumbai 27
Chennai 26
Faenza 26
Des Moines 23
Norwalk 20
Santa Clara 20
Nanjing 19
Leawood 18
Dong Ket 17
Redmond 17
Montreal 16
Rome 16
Brussels 15
Frankfurt am Main 15
Kunming 15
Rio de Janeiro 15
San Mateo 15
Toronto 15
Milan 14
Tokyo 14
Washington 14
Chicago 13
Johannesburg 13
Ardabil 12
Belo Horizonte 12
Guangzhou 12
London 12
Manchester 12
New Delhi 12
Andover 11
Augusta 11
Jinan 11
Warsaw 11
Buenos Aires 10
Nanchang 10
Scafati 10
Turku 10
Phoenix 9
Tashkent 9
Amman 8
Da Nang 8
Düsseldorf 8
Gorizia 8
Memphis 8
Mexico City 8
Nuremberg 8
San Michele al Tagliamento 8
Stockholm 8
Wuhan 8
Amsterdam 7
Atlanta 7
Brooklyn 7
Caracas 7
Curitiba 7
Denver 7
Dhaka 7
Guayaquil 7
Haiphong 7
Istanbul 7
Monmouth Junction 7
San Francisco 7
Totale 9.331
Salva come PNG Salva come JPEG
Nome #
F1FO ATP synthase is expressed at the surface of embryonic rat heart-derived H9c2 cells and is affected by cardiac-like differentiation 235
Inhibition of APE1-endonuclease activity affects cell metabolism in colon cancer cells via a p53-dependent pathway 197
Mitochondrial Adaptations in Elderly and Young Men Skeletal Muscle Following 2 Weeks of Bed Rest and Rehabilitation 191
ATPase-INHIBITORY FACTOR 1 IS A PROGNOSTIC FACTOR IN LOW GRADE ASTROCYTOMAS 189
Transformation by different oncogenes relies on specific metabolic adaptations 183
Secretion of lysosomal hydrolases by cultured human amnion epithelial cells 178
Downmodulation of mitochondrial F0F1ATPsynthase by diazoxide in cardiac myoblasts: a dual effect of the drug 175
Apoptosis is induced by decline of mitochondrial ATP synthesis in erythroleukemia cells 170
Melatonin decreases bone marrow and lymphatic toxicity of adriamycin in mice bearing TLX5 lymphoma 170
Cardiac differentiation promotes mitochondria development and ameliorates oxidative capacity in H9c2 cardiomyoblasts 168
ATPase-INHIBITORY FACTOR 1 AND OXPHOS COMPLEXES IN HUMAN GLIOMAS 168
Valutazione nutrizionale in un campione di volontari obesi inclusi in un programma di intervento nutrizionale e di attività sportiva 166
Mitochondrial energy metabolism and signalling in human glioblastoma cell lines with different PTEN gene status 164
Immunity in patients treated with cis-platinum 161
Bone marrow toxicity and antitumor action of adriamycin in relation to the antioxidant effets of melatonin 161
The inactivation of mitochondrial F1ATPase by H2O2 is mediated by iron ions not tightly bound in the protein 159
Effects of 3-month high-intensity interval training vs. moderate endurance training and 4-month follow-up on fat metabolism, cardiorespiratory function and mitochondrial respiration in obese adults 159
Caspase-independent apoptosis in Friend’s erythroleukemia cells: role of mitochondrial ATP synthesis impairment in relocation of apoptosis-inducing factor and endonuclease G 158
Early impairment of kidney function after cisplatinum administration 154
Mitochondrial bioenergetic profile and responses to metabolic inhibition in human hepatocarcinoma cell lines with distinct differentiation characteristics. 154
Knock-in reconstitution studies reveal an unexpected role of Cys-65 in regulating APE1/Ref-1 subcellular trafficking and function 152
Proteomic analysis of F1F0-ATP synthase super-assembly in mitochondria of cardiomyoblasts undergoing differentiation to the cardiac lineage 152
Alcuni tests immunitoari in pazienti cancerosi, trattati con monochemioterapia con diidrossiantracenedione (DHAD) ad alto dosaggio 149
Alcuni test immunitari in pazienti con malattie linfoproliferative, in rapporto all'età 148
Severe energy impairment consequent to inactivation of mitochondrial ATPsynthase as early event of cell death. A mechanism for the selective sensitivity to H2O2 of differentiating erythroleukemia cells 144
A 99Tc-DTPA study on platinum nephrotoxicity: glomerular lesions 142
A 99mtc-DTPA study on platinum chronic nephrotoxicity: also glomerular lesions 142
Mitochondrial and cell-surface F0F1ATPsynthase in innate and acquired cardioprotection 142
Mitochondrial bioenergetic profile of human hepatocarcinoma cell lines 141
H2O2 induces apoptosis in heme-synthesizig erytrholeukemia cells with a mechanism indeoendent from nF-kB activation and mediated by decline in mitochondrial bioenergy 141
IF1 distribution in HepG2 cells in relation to ecto F0F1ATPsynthase and calmodulin 140
Lyphocytes subpopulations in untreated patients with cancer 139
GSK3β is a key regulator of the ROS-dependent necrotic death induced by the quinone DMNQ 137
Kidney glomerular disfunction in DDP-treated patients 136
Different Fe molecular species mediate selective H2O2-damage to different moieties of F0F1ATPsynthase in intact cells, isolated mitochondria or proteoliposomes 136
Glucose-Modulated Mitochondria Adaptation in Tumor Cells: A Focus on ATP Synthase and Inhibitor Factor 1 135
New insights in the mitochondrial localization of APE1, the major apurinic/apyrimidinic endonuclease in mammals 130
A novel pathogenic mutation in the ATP5MC3 gene of ATP synthase causing dystonia is associated with autophagic and lysosomal alteration 129
Immunity during monochemotherapy with mitoxantrone: preliminary results 129
Aminoglutetimide nel carcinoma mammario metastatizzato 125
Immunity in patients treated with cis-platinum. 124
Down-regulation of the mitochondrial ATP synthase in Friend's erythroleukemia cells induced to differentiation 122
Peripheral impairments of oxidative metabolism after a 10-day bed rest are upstream of mitochondrial respiration 121
Exercise training in Tgαq*44 mice during the progression of chronic heart failure: cardiac vs. peripheral (soleus muscle) impairments to oxidative metabolism 118
Immunological study in untreated patients with breast cancer (BC) 116
Studio immunologico durante terapia con platino (DDP) in pazienti cancerosi 115
Chemotherapy (CT) effects on lymphocytes subpopulations in cancer patients 115
Chemioterapia antiblastica (CT) con /senza timopentina (random): effetti sull' immunità (I) in vivo e in vitro 113
Characteristics of iron ion bionding sites in mitochondrial F1ATPase 113
Melatonin increases the therapeutical index of adramycin 111
Metabolic plasticity of tumor cells: analysis of ATP synthase and IF1 in the glucose modulation of the oxidative metabolism 111
Is the severe energy impairment caused by H2O2 responsible for the decrease of proliferative efficienty of differentiated Friend's erythroleukemia cells? 110
An immunological study in 44 cancer patients with or without synthetic tymic immunomodulators 110
Caspase-independent apoptosis is triggered by stimuli impairing mitochondrial ATP synthesis in Friend's erythroleukemia cells 109
Inhibition of mitochondrial ATP synthase leading to ATP loss as early irreverible event of cell death 107
Immunity in cancer patients during polychemotherapy (PCH) with or wirthout cyclophosphamide (CTX) 107
Down-modulation of mitochondrial ATP synthase by diazoxide in cardiac myoblasts 107
Immunochanges during monochemotherapy in cancer patients 106
Immunity during monochemotherapy with mitoxantrone: preliminary results 105
Morphological and functional mitochondrial changes upon in vitro cardiomyogenesis 105
Cardiomyoblasts differentiation as a model to define the molecular determinants of assembly/stability of F0F1ATP synthase dimers 105
Glutathione status and malondialdheyde production as markers of oxidative stress occurred during erythroid differentiation 104
Redox status of Freind's cells influences NK-kB binding activity induced by H2O2 104
Mitochondrial bioenergetic profile and metabolic adaptation of human hepatocarcinoma cell lines 103
Effects of thymopentin in cancer patients treated with chemotherapy 102
Early and progressive glomerular kidney toxicity during cis-platinum therapy 102
The cleavage of Cyclophilin D N-terminus potentiates its ability to bind ATP Synthase 101
Treatment of shingomyelinase deficiency by repeated implantations of amniotic epithelial cells 101
Effetti del cis-platino (DDP) in monochemioterapia su alcuni parametri immunologici 101
Requirement of loosely bound Fe++/Fe+++ for the oxidative inactivation of F1ATPase 101
Endogenous pro-oxidant status and H2O2-mediated impairment of cell mitochondrial functions, ATP content and proliferative capacity 100
Differentiation potentiates oxidant injury to mitochondria by hydrogen peroxide in Friend erythroleukemia cells 100
Proteomic analysis of the supramolecular organization of F0F1ATPsynthase in bovine heart mitochondria 100
Anemia indotta dal cis-platino in monochemiotearpia. Studio preliminare 99
Cellule epiteliali amniotiche: bioreattori con secrezione specifica per la terapia di sostituzione enzimatica 98
Manipulation of iron and energy status of cells as a tool fot triggering apoptosis. Key role for inactivation of mitochondrial ATP synthase 97
Studio immunologico in cancerose sottoposte a CEP-chemioterapia, con o senza immunomodulatore 97
Pro-oxidant conditions in Friend's cells during erythroid differentiation 97
Melatonin and oxidative damage in mice liver induced by the prooxidant antitumor drug, Adriamycin 97
Immunological study in patients with brest cancer during chemotherapy (CT) including cyclophosphamide (CTX) 96
Melatonin increases the therapeutic index of the antitumor anthracycline, adriamycin 96
The challenge by oxidant stress to mitochondrial ATP synthase in intact erythroleukemia cells is enhanced by heme 96
Kidney glomerular disfunction in DDP-treated patients 94
Active Regulation of ATPsynthase by the Inhibitor Protein IF1 in Heart 94
Early impairment of kidney function after platinum administration 93
Trattamento di 4 casi di malattia di Niemann-Pick tipo B, mediante trapianto di cellule epiteliali amniotiche 93
Immunity in bresat cancer (BC) patients during DDP chemotherapy (CT) 92
Inactivation of mitochondrial ATPsynthase through manipulation of iron status as a tool for triggering apoptosis 90
Mitochondrial F1F0ATPsynthase assembly and oligomerization upon cardiomyogenic differentiation of murine cardiomyoblasts 90
Early and progressive glomerular kidney toxicity during is-platinum therapy 90
Lymphocytes subpopulations (LS) and other immunological parameters in untreated patients with cancer 89
In vivo modulation of F0F1ATPsynthase by inhibitor protein IF1 during coronary reactive hyperemia and ischemic preconditiong in goat heart 88
Mitochondrial biogenesis during differentiation of myoblasts 88
Kidney function in cancer patients during chemotherapy (CT) with DD-platinum (DDP) and mitomycin c(MMC) 87
La malattia di Gaucher: studio di un gruppo familiare del Friuli 86
Immunità in vivo in pazienti cancerosi trattati con mitoxantrone (M) in monochemioterapia 86
Implication of the lipophilic and hydrophilic moieties in the peroxide-induced oxidation of bovine heart mitochondrial H+ATP synthase 85
Native gel-based electrophoretic analysis of F1F0-ATP synthase assembly in mitochondrial biogenesis: a multitasking role of IF1 85
Mitochondria and cell susceptibility to oxidative damage as related to different iron homeostasis and redox status: a study on Friend's erythroleukemia cells induced to differentiation 84
Immunity in patients with lung cancer (LC) during various chemotherapy (CT) regimens 84
Totale 12.289
Salva come PNG Salva come JPEG
Categoria #
all - tutte 55.678
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.678
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202154 0 0 0 0 0 0 0 0 0 0 0 54
2021/2022990 19 149 26 91 62 14 35 61 10 149 196 178
2022/2023986 154 87 28 104 103 270 2 53 124 7 20 34
2023/2024365 46 28 13 7 52 63 16 8 52 27 15 38
2024/20252.401 47 145 59 77 101 155 157 163 255 132 494 616
2025/20263.876 393 367 279 335 635 351 445 138 287 352 224 70
Totale 14.898